India to Myanmar: Metoclopramide Export Trade Route

The India to Myanmar Metoclopramide corridor is one of India's established pharmaceutical export routes, with 18 shipments documented worth a combined $1.0M USD. The route is dominated by MAAN PHARMACEUTICALS LTD, which alone accounts for roughly 87% of all export value, reflecting the consolidated nature of India's metoclopramide manufacturing sector.

Across 13 active suppliers, the average shipment value stands at $56.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with metoclopramide's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 28.5%, placing it at rank #17 among India's top metoclopramide export destinations globally.

On the import side, key buyers of Indian metoclopramide in Myanmar include YAR PYE COMPANY LIMITED, SUCCESS EMPIRE TRANSPORTATION &, WIN WIN EXP IMP CO LTD,U LUN STREET and 12 others. YAR PYE COMPANY LIMITED is the single largest importer with 2 shipments valued at $884.3K USD.

India's metoclopramide exports to Myanmar are driven primarily by a handful of large-scale manufacturers. MAAN PHARMACEUTICALS LTD with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 13 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MAAN PHARMACEUTICALS LTD, ARAVIS PHARMACEUTICALS, SWISS PARENTERALS LIMITED — together account for 97% of total trade value on this route. The average shipment value of $56.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical goods/harmless medicinesfor human use-vomicare metoclopramide injcetion bp 5mg/ml, 2 ml(20,000 packs) and maxomet tablet,metoclopramide hydrochloride bp,batch no.mntfo2301,mfg.dt.08/2023,exp.dt.07/2026, suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, YAR PYE COMPANY LIMITED is the largest importer with 2 shipments worth $884.3K USD — representing 87% of all metoclopramide imports from India on this route. A total of 15 buyers are active on this corridor.